Mitotic kinesin inhibitors

Details for Australian Patent Application No. 2006227787 (hide)

Owner Merck And Co., Inc.

Inventors Coleman, Paul J.; Cox, Christopher D.; Hartman, George D.

Agent Spruson & Ferguson

Pub. Number AU-A-2006227787

PCT Pub. Number WO2006/101780

Priority 60/662,519 16.03.05 US

Filing date 10 March 2006

Wipo publication date 28 September 2006

International Classifications

A61K 31/454 (2006.01)

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

C07D 207/20 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

13 September 2007 PCT application entered the National Phase

  PCT publication WO2006/101780 Priority application(s): WO2006/101780

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

6 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006227790-Compounds and compositions as protein kinase inhibitors

2006227778-Novel thiophene sulfoximines for treating complement-mediated diseases and conditions